Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Mendelics | RCV002248990 | SCV002516255 | likely pathogenic | Hereditary pancreatitis | 2022-05-04 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV005239328 | SCV005884402 | uncertain significance | not specified | 2024-12-26 | criteria provided, single submitter | clinical testing | Variant summary: CFTR c.1066_1071delTGGGCT (p.Trp356_Ala357del) results in an in-frame deletion that is predicted to remove 2 amino acids from the encoded protein. The variant was absent in 251114 control chromosomes (gnomAD). The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. c.1066_1071delTGGGCT has been reported in the literature as a complex allele with the missense variant c.1072G>A (p.Val358Ile) in cis in individuals affected with Cystic Fibrosis (McGinniss_2005, Martinez-Hernandez_2024). These reports do not provide unequivocal conclusions about association of the variant with Cystic Fibrosis. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 38601560, 16189704). ClinVar contains an entry for this variant (Variation ID: 1685263). Based on the evidence outlined above, the variant was classified as uncertain significance. |